Journal
EXPERT REVIEW OF HEMATOLOGY
Volume 2, Issue 4, Pages 443-453Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/ehm.09.29
Keywords
CpG; donor treatment; graft versus host disease; immunity; immunoregulation; myeloid suppressor cells; Toll like receptor agonist
Categories
Ask authors/readers for more resources
Stimulation of Toll-like receptors by oligodeoxynucleotide sequences containing a CpG motif provides signals capable of triggering the innate and adaptive immune systems, thereby leading either to stimulation or suppression of immunoreactivities Similar immunoregulatory capabilities are necessary for achieving the fine balance between engraftment and graft-versus-host disease required in the setup of allogeneic cell therapy Ligation of CpG to its Toll-like receptors can be accomplished by treatment of the host or pretransplant treatment of the donor in vivo These different strategies are presented in this review, which summarizes the attempts to maximize beneficial alloreactivity against malignant or other undesirable host cells while controlling graft-versus-host disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available